UC Santa Barbara discovers cell survival gene may lead to treatments for degenerative diseases

(Santa Barbara, Calif.) Our cells are constantly making life and death decisions. A new gene that controls this life or death switch and protects cells from dying has been discovered by researchers at the University of California, Santa Barbara, as reported in the August 28 edition of the scientific journal Nature.

The discovery may provide scientists with new means for identifying drugs that combat degenerative diseases such as Lou Gehrig's disease (ALS), the destructive effects of stroke and heart diseases, autoimmune diseases, and cancer.

Chilling though it sounds, our cells are poised on the brink of death. Yet the ongoing death of some of our cells is actually essential for us to live. "Death, that is to say cell death, is a key player in biology and medicine," said Joel Rothman, associate professor of Molecular, Cellular and Developmental Biology, and leader of the UCSB research team. "Cells often commit suicide so that others may live. This is the ultimate example of altruism at the cellular level."

Why would a cell kill itself off? "Programmed cell death is one of the first lines of defense against cancer and infection by invaders such as viruses," notes Rothman. "Ironically, the failure of a wayward cell to die can actually lead to death of the individual."

By killing itself off, a malignant or infected cell can prevent the disease from spreading. However, the throttle on cell death must be carefully set. "While death is a necessary part of our survival, too much cell death is disastrous," said Rothman "That is what happens in degenerative diseases."

The gene identified by Rothman and UCSB postdoctoral researchers Tim Bloss and Eric Witze is called ICD-1 (inhibitor of cell death gene 1). It prevents normal cells from committing suicide. "As often happens in research, we were looking into an entirely different process when we stumbled across this cell death gene,"

Contact: Eileen Conrad
University of California - Santa Barbara

Page: 1 2 3

Related biology news :

1. UC Santa Barbara donates discovery to OneWorld Health that may speed disease treatment
2. Chemical society convenes regional meeting in Santa Barbara, October 28-31
3. Webcast will ensure broad public access to the UC Santa Cruz Public Forum on Human Genome Research
4. UC Santa Cruz Public Forum on the Human Genome
5. Coastal research project at UC Santa Cruz receives major boost in funding
6. UC Davis, Santa Barbara get $6 million to help estuaries
7. Future uses of MicroElectricalMechanical (MEM) systems to be featured at Santa Clara show
8. USGS Scientists To Speak On Rare Plants And Invasive Species At Santa Barbara Symposium
9. LSU researcher discovers new bird
10. MIT team discovers memory mechanism
11. OHSU team discovers compound that lacks estrogens risks

Post Your Comments:

(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: